NRIX
Nurix Therapeutics Inc
23.00$
-2.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| -84.6% | 1.9% | -0.4% | -283.6% | -413.7% | -105.7% | -316.4% | -297.1% | |
| 8.0% | 7.6% | 12.2% | 20.4% | 28.0% | 17.7% | 30.1% | 22.5% | |
| 1.2% | 1.6% | 24.1% | 53.1% | 72.8% | 43.7% | 62.2% | 45.2% | |
| 0.2% | 1.3% | 25.7% | 59.3% | 73.4% | – | – | – | |
| -67.6% | 62.8% | 204.3% | 30.6% | -49.2% | 26.1% | -33.7% | -37.6% | |
| 4.3% | 5.3% | 25.5% | 19.0% | 31.7% | 10.9% | 17.0% | 16.7% | |
| 106.8% | 27.3% | -1,427.6% | -363.9% | 70.4% | 88.7% | -472.4% | 176.1% | |
| 0.0% | -0.1% | 0.0% | 0.0% | 303.4% | – | – | – | |
| 1.4% | 0.4% | 1,902.5% | 517.3% | 303.4% | 4.2% | 890.3% | 284.2% | |
| 23.6% | 29.6% | 474.4% | -130.2% | -39.9% | -12.8% | 101.5% | 163.2% | |
| -88.8% | -3.4% | -26.0% | -302.6% | -445.4% | -116.6% | -333.4% | -313.7% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.